What is Ozempic?
Ozempic is Novo Nordisk’s injectable semaglutide brand for type 2 diabetes. Its Canadian indications also include cardiovascular and kidney-related uses in specified adult patient groups. Those criteria are product-specific; the brand name alone does not establish eligibility.
Ozempic, Wegovy and generics: what changes?
Ozempic and Wegovy both contain semaglutide. They have different product records and approved uses. An Ozempic-reference generic should not be presented as a generic version of every Wegovy presentation.
What changed in Ozempic savings support?
Novo Nordisk announced an expanded savings-card program for eligible patients with private coverage on July 6, 2026, excluding Quebec. Check current eligibility and the pharmacy’s final price.
Read the update →Before you fill your prescription
Compare the exact pen, concentration and quantity on your prescription. Generic semaglutide products may reference Ozempic; a matching ingredient alone does not establish interchangeability.
Ask your pharmacy for a quote showing the exact DIN, package, days supplied, dispensing fee and delivery. If you use an online provider, check visit and membership charges separately.
For insurance, confirm the exact DIN, any prior authorization and your remaining deductible or limits with your plan.
Check coverage steps →Product sources and review details
Sources reviewed 2026-09-20. Check the current Canadian product information with your pharmacist for dosing and safety questions.
Ozempic product source
Clarity in every comparison.